Sort by
Refine Your Search
-
Employer
-
Field
-
Across Multiple Disciplines) Center financed by the LEO Foundation. You will be part of building this new center which bridges Aarhus University, Faculty of Health and Faculty of Natural Sciences, and
-
the new DREAM (Dermatology Research Across Multiple Disciplines) Center financed by the LEO Foundation. You will be part of building this new center which bridges Aarhus University, Faculty of Health and
-
@health.sdu.dk The successful applicant will be employed in accordance with the agreement between the Ministry of Finance and AC (the Danish Confederation of Professional Associations). The closing date
-
be jointly supervised by Professor Jørgen Ellegaard Andersen and Associate Professor Shan Shan at QM. Candidate profile We encourage applications from PhDs in mathematics and related fields who possess
-
, with possibility of extension. The project is part of the larger research project “AI4NaturalFood”, which is financed by the Novo Nordisk Foundation. Start date is 1 September 2025 or as soon as possible
-
The project will be part of the new DREAM (Dermatology Research Across Multiple Disciplines) Center financed by the LEO Foundation. You will be part of building this new center which spans over Aarhus
-
The project will be part of the new DREAM (Dermatology Research Across Multiple Disciplines) Center financed by the LEO Foundation. You will be part of building this new center which spans over Aarhus
-
research group as well as the Centre for Cold Studies. These affiliations ensure strong local research support and mentoring. Eligibility and requirements: PhD in History, Rhetoric, Digital Humanities
-
, you will be focusing on the topic of Brain Neuro-Adaptability to Pain, in particular brain oscillations in pain conditions and non-invasive brain stimulation. You will be working alongside PhD students
-
) consist of 4 Post docs. 2 PhD students, and 1 research assistant. Core focus of the group includes both basic science and applied science with societal impact. In 2022 the biotech company TriptoBIO (http